XML 33 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The assumptions used to value SARs granted during 2019 were as follows:
 
5-year vesting SARs
7-year vesting SARs
Risk-free interest rate
2.43
%
2.51
%
Expected dividend yield
2.30
%
2.30
%
Expected common stock volatility
35.71
%
40.84
%
Expected life
6.5 years

7.0 years

Schedule of Share-based Compensation, Stock Options, Activity
A summary of activity in our Plans during the first nine months of 2019 and 2018 is as follows:
 
For the Nine Months Ended September 30,
 
2019
 
Options/SARs
 
Aggregate
Intrinsic
Value (in thousands)
 
Remaining
Contractual
Term (Yrs.)
 
Weighted-Average
Exercise Price
Outstanding, January 1
232,091

 
 
 
 
 
$
17.36

Granted
138,125

 
 
 
 
 
23.94

Exercised
(31,413
)
 
 
 
 
 
11.83

Forfeited

 
 
 
 
 

Expired

 
 
 
 
 

Outstanding, September 30
338,803

 
$
1,745

 
7.41
 
$
20.56

 
 
 
 
 
 
 
 
Exercisable, September 30
112,989

 
$
1,063

 
5.59
 
$
16.32



 
For the Nine Months Ended September 30,
 
2018
 
Options/SARs
 
Aggregate
Intrinsic
Value
(in thousands)
 
Remaining
Contractual
Term (Yrs.)
 
Weighted-Average
Exercise Price
Outstanding, January 1
250,291

 
 
 
 
 
$
17.75

Granted

 
 
 
 
 

Exercised
(1,600
)
 
 
 
 
 
17.79

Forfeited
(3,200
)
 
 
 
 
 
25.5

Expired

 
 
 
 
 

Outstanding, September 30
245,491

 
$
1,645

 
6.62
 
$
17.65

 
 
 
 
 
 
 
 
Exercisable, September 30
109,324

 
$
898

 
5.55
 
$
15.77